Scarica l'app Stockscreener
84.38
0.54%
-0.46
Dopo l'orario di chiusura:
84.00
-0.38
-0.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DXCM Giù?
Forum
Previsione
Frazionamento azionario
Dexcom Inc Borsa (DXCM) Ultime notizie
Top 10 Medical Device Predictions for 2025 - GlobeNewswire Inc.
Wealthcare Advisory Partners LLC Has $998,000 Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Sold by Gateway Investment Advisers LLC - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Short Interest Down 5.7% in December - MarketBeat
DexCom raised to outperform by Baird - MSN
Dexcom inks glucose biosensor partnership with Life Time - Drug Delivery Business News
DexCom (NASDAQ:DXCM) shareholder returns have been decent, earning 44% in 5 years - Yahoo Finance
DexCom, Inc. (NASDAQ:DXCM) Shares Bought by Sax Wealth Advisors LLC - MarketBeat
Avanza Fonder AB Takes Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Legacy Wealth Asset Management LLC Acquires New Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom: Fairly Priced In 2025; Why I'm Not Expecting A Share Price Comeback - Seeking Alpha
Woodstock Corp Cuts Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom (NASDAQ:DXCM) Stock Price Up 3.7%Here's What Happened - MarketBeat
JPM25 recap: Robotics, PFA and OTC glucose sensors in the spotlight - MedTech Dive
Baird R W Upgrades DexCom (NASDAQ:DXCM) to Strong-Buy - MarketBeat
Latin America Continuous Glucose Monitoring Device Market Projected To Witness Substantial Growth, - EIN News
Fifth Third Wealth Advisors LLC Has $477,000 Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Sold by Oak Thistle LLC - MarketBeat
DexCom (NASDAQ:DXCM) Stock Unloaded Rep. Kevin Hern - MarketBeat
DexCom Stock Up Following Strong Preliminary Q4 Results & 2025 Outlook - MSN
Why DexCom, Inc. (DXCM) Is Skyrocketing - Insider Monkey
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
DexCom raised to outperform by Baird (DXCM:NASDAQ) - Seeking Alpha
Piper Sandler bullish on DexCom shares citing growth potential and new catalysts - MSN
Baird raises DexCom stock to outperform, target to $104 - MSN
Expert Outlook: DexCom Through The Eyes Of 11 Analysts - Benzinga
This Netflix Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Outlook Wealth Advisors LLC Buys New Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom (NASDAQ:DXCM) Upgraded by Robert W. Baird to Outperform Rating - MarketBeat
2 Healthcare Stocks to Buy Hand Over Fist in January - Yahoo Finance
DexCom, Inc. (NASDAQ:DXCM) Holdings Decreased by Assenagon Asset Management S.A. - MarketBeat
180 Wealth Advisors LLC Invests $255,000 in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Dexcom CEO talks Stelo sensor launch, OTC strategy - MedTech Dive
Earnings Summary: DexCom reports preliminary Q4 2024 results - AlphaStreet
JP Morgan 2025: Dexcom shares up 5% after 2025 outlook forecasts $4.6bn in revenue - Yahoo Finance
DexCom revenue increases 8% in Q4 2024 - Medical Buyer
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - MSN
DexCom (NASDAQ:DXCM) Shares Gap UpShould You Buy? - MarketBeat
CHICAGO TRUST Co NA Grows Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom stock rises on 2025 outlook - MSN
DexCom stock gains, sees 14% revenue growth in 2025 By Investing.com - Investing.com Canada
DexCom stock gains, sees 14% revenue growth in 2025 - Investing.com India
DexCom stock rises on 2025 outlook (NASDAQ:DXCM) - Seeking Alpha
DexCom Q4 Revenue Hits $1.1B as International Sales Surge 17%, Sets Ambitious 2025 Growth Target - StockTitan
DexCom price target raised to $89 from $86 at Bernstein - MSN
Abbott, Dexcom End UPC Feud Over Glucose Monitor Patent - Law360
DexCom (NASDAQ:DXCM) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
42,021 Shares in DexCom, Inc. (NASDAQ:DXCM) Bought by Watts Gwilliam & Co. LLC - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Purchased by First Hawaiian Bank - MarketBeat
Diversified Trust Co Lowers Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Why Is Jim Cramer Mystified by DexCom, Inc. (DXCM)’s Earnings Miss and Competitive Challenges? - Insider Monkey
Why Abbott and Dexcom buried the hatchet in their glucose monitor patent fight - Crain's Chicago Business
Brokerages Set DexCom, Inc. (NASDAQ:DXCM) Target Price at $98.00 - MarketBeat
Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
DexCom and Abbott withdraw patent dispute from UPC - MLex
DexCom to Present Corporate Strategy at J.P. Morgan Healthcare Conference 2025 - StockTitan
Decoding DexCom's Options Activity: What's the Big Picture? - Benzinga
DexCom's (NASDAQ:DXCM) Returns On Capital Are Heading Higher - Yahoo Finance
DXCM Stock Gains on the Launch of Proprietary Generative AI Platform - MSN
Is DexCom, Inc. (NASDAQ:DXCM) A High Quality Stock To Own? - Simply Wall St
Everence Capital Management Inc. Cuts Stake in DexCom, Inc. (NASDAQ:DXCM) - Defense World
0.31%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):